The tumor microenvironment’s role in the response to immune checkpoint blockade
Konstantinos AliazisDepartment of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USAAnthos ChristofidesDepartment of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USARushil ShahDepartment of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USAYao Yu YeoCancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USASizun JiangCancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USAAlain CharestCancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USAVassiliki A. BoussiotisCancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. [email protected]
2025en
ABI
Abstract
No abstract available.
Identifiers
Citations and references
Cited by 40 references